| Jessica Fabrizio, PT,DPT | |
|
66 Powerhouse Rd Ste 304, Roslyn Heights, NY 11577-1372 | |
| (516) 621-1848 | |
| Not Available |
| Full Name | Jessica Fabrizio |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 66 Powerhouse Rd Ste 304, Roslyn Heights, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053039313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 049273 (New York) | Primary |
| Provider Name | Sports Physical Therapy Occupational Therapy And Rehabilitation Servic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770540593 PECOS PAC ID: 0446140446 Enrollment ID: O20040315001603 |
News Archive
Most people would agree that stress increases your risk for illness and this is particularly true for severe long-term stresses, such as caring for a family member with a chronic medical illness. However, we still have a relatively limited understanding of exactly how stress contributes to the risk for illness. In the August 15th issue of Biological Psychiatry, researchers shed new light on one link between stress and illness by describing a mechanism through which stress alters immune function.
Elevated insulin levels in the blood appear to raise the risk of breast cancer in postmenopausal women, according to researchers at Albert Einstein College of Medicine of Yeshiva University. Their findings are published in the online version of the International Journal of Cancer.
Inspire Pharmaceuticals, Inc. announced that DIQUAS Ophthalmic Solution 3% (diquafosol tetrasodium) received pricing approval and was launched for sale today in Japan by its partner, Santen Pharmaceutical Co., Ltd. Inspire will receive a related milestone payment of $1.25 million in the fourth quarter of 2010 and is also entitled to receive payments based upon a tiered royalty rate on net sales of DIQUAS in Japan, with a minimum rate in the high single digits and a maximum rate in the low double digits.
An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Fabrizio, PT,DPT 3 Huntington Quadrangle Ste 103n, Melville, NY 11747-4601 Ph: (516) 474-2816 | Jessica Fabrizio, PT,DPT 66 Powerhouse Rd Ste 304, Roslyn Heights, NY 11577-1372 Ph: (516) 621-1848 |
News Archive
Most people would agree that stress increases your risk for illness and this is particularly true for severe long-term stresses, such as caring for a family member with a chronic medical illness. However, we still have a relatively limited understanding of exactly how stress contributes to the risk for illness. In the August 15th issue of Biological Psychiatry, researchers shed new light on one link between stress and illness by describing a mechanism through which stress alters immune function.
Elevated insulin levels in the blood appear to raise the risk of breast cancer in postmenopausal women, according to researchers at Albert Einstein College of Medicine of Yeshiva University. Their findings are published in the online version of the International Journal of Cancer.
Inspire Pharmaceuticals, Inc. announced that DIQUAS Ophthalmic Solution 3% (diquafosol tetrasodium) received pricing approval and was launched for sale today in Japan by its partner, Santen Pharmaceutical Co., Ltd. Inspire will receive a related milestone payment of $1.25 million in the fourth quarter of 2010 and is also entitled to receive payments based upon a tiered royalty rate on net sales of DIQUAS in Japan, with a minimum rate in the high single digits and a maximum rate in the low double digits.
An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.
› Verified 8 days ago
Mrs. Meryl Cohen, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 189 Garden St, Roslyn Heights, NY 11577 Phone: 917-620-5381 | |
Kerrie Blumberg, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Corn Crib Ln, Roslyn Heights, NY 11577 Phone: 516-801-3340 | |
Jay Patel, PT,DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 66 Powerhouse Rd Ste 304, Roslyn Heights, NY 11577 Phone: 631-621-1170 | |
Wellcare Physical Therapy Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 53 Center Ct, Roslyn Heights, NY 11577 Phone: 347-203-6569 | |
Ms. Laura Louise Eisenzopf, MS, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Expressway Plz Ste 106, Roslyn Heights, NY 11577 Phone: 516-621-2681 | |
Rehab Alternatives, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 South Service Rd., Suite 101, Roslyn Heights, NY 11577 Phone: 516-801-6111 Fax: 516-801-6110 |